# US 2026/0185126 A1 · Pharmaceutical compositions/medications made from White Tumeric (Curcuma Aromatica Salisb.) compounds having enhanced inhibitory urease enzyme activities and methods of manufacturing the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0185126 A1
- Document ID: US20260185126A1
- Status: Published application
- Kind: A1
- Application number: 19/051,237
- Filed: 2025-02-12
- Published: 2026-07-02
- Earliest claimed: 2024-12-27
- Assignees: Vietnam National University Ho Chi Minh City; VNUHCM-University of Science
- Inventors: THANH MAI THI NGUYEN; NHAN TRUNG NGUYEN; THO HUU LE; NHAT TRUONG VAN DO; HAI XUAN NGUYEN
- Web page: https://patentgrep.com/patent/US20260185126A1

## CPC

- C12P 7/18: polyhydric
- C07C 39/12: polycyclic with no unsaturation outside the aromatic rings
- C07C 69/21: of hydroxy compounds with more than three hydroxy groups (esters of sugars C07H)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

A method and a composition, characterized as having enhanced inhibitory urease activities, having a diarylheptanoid compound having a first aryl moiety group coherently bonded to a linear heptane moiety and a second aryl moiety group described by the following formula:

## Claims

### Claim 1

A composition, comprising:
a diarylheptanoid compound, having a first aryl moiety covalently bonded to a linear heptane moiety and to a second aryl moiety, described by the following formula:
Wherein R1 is a first functional groups at a location 3,5 of said linear heptane moiety,
R2 is a second functional group at a location 3 of said first aryl group,
R3 is a third functional group at a location 5 of said first aryl group,
R4 is a fourth function group at a third location of said second aryl group, and
OH is a hydroxyl functional group at a fifth location of said second aryl group.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said compound is extracted and isolated from a white turmeric (Curcuma aromatica Salisb.).

### Claim 3 (depends on 2)

The composition of claim 2 wherein said first functional group R1 is a hydroxyl group, said second functional group R2 is a hydroxyl group (OH), said third functional group R3 and said fourth functional group R4 are hydrogen (H), which is defined by the following formula:

### Claim 4 (depends on 3)

The composition of claim 3 wherein said first functional groups R1 at location 3,5 chain are on the same side (-syn) of said linear heptane moiety.

### Claim 5 (depends on 4)

The composition of claim 4 characterized by a half maximal inhibitory concentration (IC50) of 9.6 μM against urease enzyme.

### Claim 6 (depends on 5)

The composition of claim 5 characterized by a binding affinity of −6.88 kcal/mol with said urease enzyme.

### Claim 7

A method for synthesizing a diarylheptanoid composition characterized by a inhibitory urease activity, comprising:
(a) preparing white turmeric rhizomes (C. aromatic);
(b) isolating and extracting said diarylheptanoid compound from said white turmeric rhizomes to obtain a plurality of sub-fractions;
(c) modeling and optimizing said plurality of sub-fractions using a structure activity relationship (SAR), a half maximal inhibitory concentration (IC50), molecular docking, and electronic structure calculations to select a precursor sub-fraction and to design an optimal sub-fraction that have the highest IC50 among said sub-fractions; and
(d) performing chemical reactions of said precursor sub-fraction to obtain said plurality of sub-fractions which are defined by the formula:
wherein R1 is a first functional groups at a location 3,5 of said linear heptane chain,
R2 is a second functional group at a location 3 of said first aryl group,
R3 is a third functional group at a location 5 of said first aryl group,
R4 is a fourth function group at a third location of said second aryl group, and OH is a hydroxyl functional group at a fifth location of said second aryl group

### Claim 8 (depends on 7)

The method of claim 7 wherein
said white turmeric comprises alkaloids, terpenoids, flavonoids, steroids, saponins, tannins, phenols, phytosterols, gilycosides, protein amino acids, and volatile essential oils.

### Claim 9 (depends on 8)

The method of claim 8 wherein said pre-cursor sub-fraction is defined by the formula:
Wherein OAc is Acetoxyl functional group.

### Claim 10 (depends on 7)

The method of claim 7 wherein said step (a) further comprises cleaning and drying said white turmeric rhizomes.

### Claim 11 (depends on 10)

The method of claim 10 wherein said isolating and extracting of step (b) further comprising using a Soxhlet extractor with methanol as a solvent.

### Claim 12 (depends on 11)

The method of claim 11 wherein said sub-fractions are suspended in water and partitioned with n-hexane to eliminate fatty impurities.

### Claim 13 (depends on 12)

The method of claim 12 wherein said plurality of sub-fractions are obtained by a silica gel column chromatography using acetone-CHCl3 gradient mixture.

### Claim 14 (depends on 13)

The method of claim 13 wherein said step (c) further comprising selecting said sub-fractions having a inhibitory urease activities defined by half maximal inhibitory concentration (IC50) of 9.6 μM against a urease enzyme and docking affinities with urease enzymes of −6.88 kcal/mol with said urease enzyme.

### Claim 15 (depends on 14)

The method of claim 14 wherein said deacetylation reaction in step (d) further comprises performing a deacetylation reaction of said pre-cursor sub-fraction to obtain said plurality of sub-fractions.

### Claim 16 (depends on 15)

The method of claim 15 wherein said optimal composition is defined by a formula:

### Claim 17 (depends on 7)

The method of claim 7 wherein said deacetylation reaction of said precursor further comprises mixing Hydrochloric acid (HCl) with 36.5% strength and methanol (MeOH), wherein a weight or volume ratio (% w/w or % v/v) between MeOH and HCl is 30:1, wherein a weight or volume (% w/w or % v/v) between said precursor sub-fraction and methanol is 10:3.

### Claim 18 (depends on 17)

The method of claim 17 further comprising stirring said mixture of HCl and MeOH at 200 rounds per minute at room temperature and for 24 hours.

### Claim 19 (depends on 18)

The method of claim 18 wherein water is removed by using sodium sulfate (Na2SO4) to obtain a resultant sub-fraction.

### Claim 20 (depends on 19)

The method of claim 19 further comprising performing column chromatography with CHCl3:MeOH at volume or weight ratio (% w/w or % v/v) of 95:5 of said resultant sub-fraction to obtain said optimal sub-fraction.
